StonvexLoading…
StonvexStonvexStonvexCore line items from AAP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.60B | $9.09B | $9.21B | $9.15B |
Operating Income | $-43.00M | $-713.00M | $39.00M | $524.62M |
Net Income | $44.00M | $-336.00M | $30.00M | $464.40M |
EPS (Diluted) | $0.73 | $-5.61 | $0.50 | $7.65 |
Total Assets | $11.83B | $10.80B | $12.28B | $11.99B |
Total Liabilities | $9.63B | $8.63B | $9.76B | $9.39B |
Cash & Equivalents | $3.12B | $1.87B | $488.05M | $270.81M |
Free Cash Flow OCF − CapEx | $-298.00M | $-96.00M | $61.00M | $337.81M |
Shares Outstanding | 60.00M | 60.00M | 59.51M | 59.26M |